Skip to content

← All news

Markets

An2 therapeutics director Robin Readnour sells $97,322 in shares

1 source ·1 article ·Sep 9, 01:18 UTC AN2 Therapeutics

Covered by 1 outlet

All coverage · 1 article

Investing.com Canada ·Sep 9, 01:18 UTC

An2 therapeutics director Robin Readnour sells $97,322 in shares